Word

Status

Pending

Status Code

730

Status Date

Monday, August 12, 2024

Serial Number

97849984

Mark Type

2

Filing Date

Tuesday, March 21, 2023

Published for Opposition

Tuesday, January 16, 2024

Trademark Owner History

Pfizer Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

44 Medical information services, namely, providing information related to the prevention of influenza; online information services, namely, providing information related to the prevention of influenza

The mark consists of a stylized image of DNA composed of a brushed wavy line with two horizontal brushed lines coming out of the top left and two horizontal brushed lines coming out of the bottom right.
Color is not claimed as a feature of the mark.

Trademark Events

Mar 24, 2023

New Application Entered

Apr 13, 2023

New Application Office Supplied Data Entered

Apr 14, 2023

Notice Of Design Search Code E-Mailed

Dec 11, 2023

Assigned To Examiner

Dec 13, 2023

Approved For Pub - Principal Register

Jan 16, 2024

Official Gazette Publication Confirmation E-Mailed

Dec 27, 2023

Notification Of Notice Of Publication E-Mailed

Jan 16, 2024

Published For Opposition

Mar 12, 2024

Noa E-Mailed - Sou Required From Applicant

Aug 12, 2024

Sou Teas Extension Received

Aug 12, 2024

Notice Of Approval Of Extension Request E-Mailed

Aug 12, 2024

Sou Extension 1 Filed

Aug 12, 2024

Sou Extension 1 Granted